111 (NASDAQ:YI – Get Free Report)‘s stock had its “sell (e+)” rating reissued by equities researchers at Weiss Ratings in a research note issued on Saturday,Weiss Ratings reports.
111 Stock Performance
NASDAQ YI opened at $6.59 on Friday. 111 has a twelve month low of $4.14 and a twelve month high of $15.80. The stock has a market capitalization of $56.34 million, a PE ratio of -1.65 and a beta of 0.41. The stock has a 50-day simple moving average of $6.58 and a 200 day simple moving average of $7.74.
111 (NASDAQ:YI – Get Free Report) last posted its quarterly earnings data on Wednesday, November 27th. The company reported ($0.20) earnings per share for the quarter.
111 Company Profile
111, Inc engages in the provision of pharmaceutical products and medical services through online retail pharmacy and indirectly through offline pharmacy network. It operates through the B2C and B2B segments. The B2C segment engages in the sale of pharmaceutical and other health and wellness products directly to consumers through 1 Drugstore and its offline pharmacies.
Featured Stories
- Five stocks we like better than 111
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- How to Invest in Small Cap Stocks
- NYSE Stocks Give Investors a Variety of Quality Options
- These Are the Dividend Stocks Insiders Bought in January
- Want to Profit on the Downtrend? Downtrends, Explained.
- How the ‘No Buy’ Trend of 2025 Is Boosting These 3 Stocks
Receive News & Ratings for 111 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 111 and related companies with MarketBeat.com's FREE daily email newsletter.
